Anti-bevacizumab Aptamer(Cat#: CTMM-0223-JL11)

This product is an aptamer which binds to the Bevacizumab with an affinity of <200 nM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Antibody
Target Bevacizumab
Alternative Names N/A
Gene ID N/A
UniProt ID N/A
Target Overview Bevacizumab is a humanized monoclonal antibody (mAb) against vascular endothelial growth factor A, and is used alone or with other drugs to treat metastatic colon cancer, lung cancer, renal cancer, ovarian cancer, and glioblastoma.
Chemical Modification DNA
Length 20-40 nt
Affinity (Kd) <200 nM
Binding Conditions/Buffer 50 mM phosphate buffer (pH 8.5) containing 1 mM EDTA to adjust the concentration to 1μM
GC Content 58
Molecular Weight 7446.9
Extinction Coefficient 225500
nmoles/OD260 4.067
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry